Letter from the Editor Presented ByPeter van de Kerkhof, Radboudumc, the Netherlands ConferenceWCD 2023 31 August, 2023 18:18
Rocatinlimab delivers efficacy and safety in atopic dermatitis Presented ByProf. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, NY, USA ConferenceWCD 2023 31 August, 2023 18:08
Head-to-head: paraffin- versus ceramide-based moisturiser for paediatric AD Presented ByProf. Sachin Gupta, All India Institute of Medical Sciences, India ConferenceWCD 2023 31 August, 2023 18:06
JAK inhibitors for AD in the real world Presented ByDr Yik Weng, National Skin Centre, Singapore ConferenceWCD 2023 31 August, 2023 18:02
Novel JAK1 inhibitor for patients with atopic dermatitis Presented ByJianzhong Zhang, Peking University People’s Hospital, China TrialPhase 3, QUARTZ3 ConferenceWCD 2023 31 August, 2023 18:00
Can lebrikizumab maintain response rates in atopic dermatitis? Presented ByProf. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, NY, USA TrialPhase 3, ADvocate 1 and ADvocate 2 ConferenceWCD 2023 31 August, 2023 17:58
Most patients with AD on dupilumab stick with this drug long-term Presented ByDr Elena Pezzolo, San Bortolo Hospital, Italy ConferenceWCD 2023 31 August, 2023 17:56
Botulinum toxin A might provide efficacious treatment option for nail psoriasis Presented ByDr Premjit Juntongjin, Thammasat University, Thailand ConferenceWCD 2023 31 August, 2023 17:53
POETYK PSO-1 and 2: Long-term efficacy results of deucravacitinib in plaque psoriasis Presented ByProf. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, NY, USA TrialPOETYK PSO-LTE ConferenceWCD 2023 31 August, 2023 17:52
Encouraging results for first oral IL-23 receptor antagonist in plaque psoriasis Presented ByDr Robert Bissonnette, Innovaderm Research, Canada TrialPhase 2, FRONTIER 1 ConferenceWCD 2023 31 August, 2023 15:35
Subcutaneous spesolimab for GPP flare prevention Presented ByProf. Bruce Strober, Yale University School of Medicine, CT, USA TrialEffisayil 2 ConferenceWCD 2023 31 August, 2023 15:32
Knocking out psoriasis with high-dose risankizumab? Presented ByDr Andrew Blauvelt, Oregon Medical Research Center, OR, USA TrialPhase 2, KNOCKOUT ConferenceWCD 2023 31 August, 2023 15:30
Deucravacitinib versus other systemic therapies in Asian patients with psoriasis Presented ByProf. Tsen-Fang Tsai, (National Taiwan University Hospital, Taiwan ConferenceWCD 2023 31 August, 2023 15:26
Patients with AA report high long-term regrowth rates with baricitinib Presented ByDr Maryanne Senna, Harvard Medical School, MA, USA TrialBRAVE-AA1 and BRAVE-AA2 ConferenceWCD 2023 31 August, 2023 15:22
Can ritlecitinib deliver long-term efficacy in alopecia areata? Presented ByProf. Melissa Piliang, Cleveland Clinic, OH, USA TrialPhase 3, ALLEGRO ConferenceWCD 2023 31 August, 2023 15:18
TikTok videos on hair disorders lack reliability Presented ByDr Betty Nguyen, University of Miami, FL, USA ConferenceWCD 2023 31 August, 2023 15:14
Spesolimab appears successful in hidradenitis suppurativa Presented ByProf. Afsaneh Alavi, Mayo Clinic, MN, USA ConferenceWCD 2023 31 August, 2023 15:12
Promising results for paroxetine in rosacea Presented ByDr Yingxue Huang, Central South University, China TrialPRRERCT ConferenceWCD 2023 31 August, 2023 15:10
Novel PPARγ modulator reduces acne manifestations Presented ByProf. Mauro Picardo, International Medical University, Italy TrialPhase 3, GEDACNE ConferenceWCD 2023 31 August, 2023 15:07
Microencapsulated benzoyl peroxide shifts skin microbiome in rosacea Presented ByProf. Raja Sivamani, Pacific Skin Institute, CA, USA ConferenceWCD 2023 31 August, 2023 15:04
OLYMPIA 2: Positive results for nemolizumab in prurigo nodularis Presented ByProf. Sonja Ständer, University Hospital Münster, Germany TrialPhase 3, OLYMPIA 2 ConferenceWCD 2023 31 August, 2023 14:59
PRFM or PRP therapy for trophic ulcers due to leprosy? Presented ByProf. Amrita Sil, Rampurhat Government Medical College & Hospital, India ConferenceWCD 2023 31 August, 2023 13:19
Large teledermatology project in a remote island in Eastern Indonesia Presented ByDr Marlous Grijsen, University of Oxford, UK ConferenceWCD 2023 31 August, 2023 12:56
Can AI-driven teledermatology increase access to healthcare in rural African settings? Presented ByMr Philippe Gottfrois, Basel University, Switzerland ConferenceWCD 2023 31 August, 2023 12:54
Oleogel-S10 shows long-term efficacy and safety in dystrophic epidermolysis bullosa Presented ByProf. Dedee Murrell, University of New South Wales, Australia TrialPhase 3, EASE ConferenceWCD 2023 31 August, 2023 11:50
Picosecond alexandrite laser safe and effective in benign pigmentary disorders Presented ByDr Kentaro Oku, Hills Grace Clinic, Japan ConferenceWCD 2023 31 August, 2023 11:46
Gentamicin improves symptoms in paediatric Nagashima-type palmoplantar keratosis Presented ByDr Shan Wang, National Center for Children’s Health, China ConferenceWCD 2023 31 August, 2023 11:41